ClinicalIntelPulse

FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.

Open endpoint ↗

Price per call: $0.25
Chain: Base
Method: GET
Paid calls · 30 days: 1

Call it from code

This API is run by its own provider and paid directly through x402. We list it so you can find it; we don't route or hold the payment.

import { x402Client, wrapFetchWithPayment } from "@x402/fetch";
import { registerExactEvmScheme } from "@x402/evm/exact/client";

const client = new x402Client();
registerExactEvmScheme(client, { signer: agentAccount });

const pay = wrapFetchWithPayment(fetch, client);
const res = await pay("https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook", { method: "GET" });
console.log(await res.json());

https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook